Discovery of a novel class of triazolones as Checkpoint Kinase inhibitors-Hit to lead exploration

被引：17

作者：

Oza, Vibha ^{[1
]}

Ashwell, Susan ^{[1
]}

Brassil, Patrick ^{[1
]}

Breed, Jason ^{[2
]}

Deng, Chun ^{[1
]}

Ezhuthachan, Jay ^{[1
]}

Haye, Heather ^{[2
]}

Horn, Candice ^{[1
]}

Janetka, James ^{[1
]}

Lyne, Paul ^{[1
]}

Newcombe, Nicholas ^{[2
]}

Otterbien, Ludo ^{[2
]}

Pass, Martin ^{[2
]}

Read, Jon ^{[2
]}

Roswell, Sian ^{[2
]}

Su, Mei ^{[1
]}

Toader, Dorin ^{[1
]}

Yu, Dingwei ^{[1
]}

Yu, Yan ^{[1
]}

Valentine, Anna ^{[2
]}

Webborn, Peter ^{[2
]}

White, Ann ^{[2
]}

Zabludoff, Sonya ^{[1
]}

Zheng, Xiaolan ^{[1
]}

机构：

[1] AstraZeneca R&D Boston, Waltham, MA 02451 USA

[2] AstraZeneca R&D Alderley Pk, Macclesfield SK10 4TG, Cheshire, England

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2010年 / 20卷 / 17期

关键词：

Triazolones; CHK1; Checkpoint Kinase inhibitors; PROTEIN-KINASE; UCN-01;

D O I：

10.1016/j.bmcl.2010.07.015

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Checkpoint Kinase-1 (Chk1, CHK1, CHEK1) is a Ser/Thr protein kinase that mediates cellular responses to DNA-damage. A novel class of Chk1 inhibitors, triazoloquinolones/triazolones (TZ's) was identified by high throughput screening. The optimization of these hits to provide a lead series is described. (C) 2010 Elsevier Ltd. All rights reserved.

引用

页码：5133 / 5138

页数：6

共 50 条

[41] Discovery of potent and selective rhodanine type IKKβ inhibitors by hit-to-lead strategy
Song, Hyeseung
Lee, Yun Suk
Roh, Eun Joo
Seo, Jae Hong
Oh, Kwang-Seok
Lee, Byung Ho
Han, Hogyu
Shin, Kye Jung
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (17) : 5668 - 5674
[42] Discovery of pyrazolo[1,5-a]pyrimidin-7-amine derivatives as mTOR kinase domain inhibitors: Hit to lead optimization
Deng, Yongqi
Sun, Binyuan
Shipps, Gerald
Matthew, Richards
Meng, Zhaoyang
Windsor, Williama
Zeng, Hongbo
Long, Brian
Xiao, Li
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 248
[43] DISCOVERY OF NOVEL KINASE INHIBITORS FOR THE TREATMENT OF HEPATOCELLULAR CARCINOMA
Toffanin, S.
Cabellos, L.
Dong, H.
Alsinet, C.
Harrington, A.
Cornella, H.
Reddy, R. V.
Reddy, P. M.
Llovet, J. M.
JOURNAL OF HEPATOLOGY, 2013, 58 : S446 - S447
[44] Discovery of Novel α-Carboline Inhibitors of the Anaplastic Lymphoma Kinase
Mologni, Luca
Tardy, Sebastien
Zambon, Alfonso
Orsato, Alexandre
Bisson, William H.
Ceccon, Monica
Viltadi, Michela
D'Attoma, Joseph
Pannilunghi, Sara
Vece, Vito
Bertho, Jerome
Goekjian, Peter
Scapozza, Leonardo
Gambacorti-Passerini, Carlo
ACS OMEGA, 2022, 7 (20): : 17083 - 17097
[45] Discovery of wrightiadione as a novel template for the TrkA kinase inhibitors
Jeong, Yujeong
Lim, Sang Min
Hong, Sungwoo
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 25 (22) : 5186 - 5189
[46] Discovery of novel selective spleen tyrosine kinase inhibitors
Northrup, Alan B.
Altman, Michael D.
Andresen, Brian M.
Anthony, Neville J.
Arrington, Kenneth L.
Bhat, Sathesh
Bienstock, Corey E.
Black, Cameron
Burch, Jason
Butcher, John W.
Childers, Kaleen Konrad
Cote, Bernard
Deschenes, Denis
di Francesco, Emilia
Donofrio, Anthony
Ducharme, Yves
Dupont-Gaudet, Kristina
Ellis, J. Michael
Fischer, Christian
Fournier, Jean-Francois
Friesen, Rick
Gauthier, Jacques Yves
Grimm, Jonathan B.
Guay, Daniel
Guerin, David J.
Haidle, Andrew M.
Jewell, James P.
Kattar, Solomon D.
Li, Chaomin
Lim, Jongwon
Lee, Sandra
Liu, Yuan
Machacek, Michelle R.
Maddess, Matthew L.
Miller, Thomas A.
O'Boyle, Brendan M.
Otte, Ryan D.
Peterson, Scott L.
Petrocchi, Alessia
Reutershan, Michael H.
Romeo, Eric T.
Robichaud, Joel S.
Schell, Adam J.
Siu, Tony
Smith, Graham F.
Spencer, Kerrie B.
Taoka, Brandon M.
Trotter, B. Wesley
Yang, Liping
Woo, Hyun Chong
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 247
[47] Discovery and synthesis of novel class of dopamine transporter inhibitors using an in silico lead multiplying design approach
Urge, Laszlo
Dorman, Gyorgy
Papp, Akos
Bucsai, Agota
Darvas, Ferenc
Sasvari-Szekely, Maria
Sziraki, Istvan
Fujita, Toshio
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2006, 231
[48] Virtual Screening and Discovery of Novel Aurora Kinase Inhibitors
Raghu, R.
Devaraji, Vinod
Leena, K.
Riyaz, Sd.
Rani, Polavaru Baby
Kumar, Suneel B.
Naik, Pradeep Kumar
Dubey, P. K.
Velmurugan, Devadasan
Vijayalakshmi, M.
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2014, 14 (17) : 2006 - 2019
[49] Discovery and in vitro optimization of a novel class of PTPγ inhibitors
Gerritz, Samuel W.
Zhai, Weixu
Kostich, Walter A.
Huang, Yanling
Appiah, Kingsley K.
O'Connell, Jonathan C.
Beno, Brett R.
Sheriff, Steven
Kish, Kevin F.
Goldfarb, Valentina
Gao, Mian
Kiefer, Susan E.
McDonnell, Patricia A.
Dzierba, Carolyn D.
Shi, Shuhao
Zhu, Shirong
Hamman, Brian
Allen, Jason
Westphal, Ryan S.
Poss, Michael
Bronson, Joanne J.
Macor, John E.
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 238
[50] Lead drug discovery from imidazolinone derivatives with Aurora kinase inhibitors
Sivakumar, Bathula
Kaliappan, Ilango
PHARMACIA, 2023, 70 (04) : 1529 - 1540

← 1 2 3 4 5 →